Roxane Agrees To Delay Launch Of Generic Asacol
A federal judge on Tuesday put a patent infringement suit over inflammatory bowel disorder drug Asacol on hold, following defendant generic-drug maker Roxane Laboratories Inc.'s agreement to delay the launch of...To view the full article, register now.
Already a subscriber? Click here to view full article